Anthony K.C. Chan

What is he best known for?

The fields of study he is best known for:

• Internal medicine
• Surgery
• Cancer

His primary areas of investigation include Pediatrics, Surgery, Internal medicine, Low molecular weight heparin and Thrombosis. The study incorporates disciplines such as Odds ratio, Epidemiology, Cohort study, Stroke and Cohort in addition to Pediatrics. The Surgery study combines topics in areas such as Observational study and Risk factor.

In his study, which falls under the umbrella issue of Internal medicine, Neuroendocrine tumors, Carcinoid tumors, Perforation and Radiology is strongly linked to Gastroenterology. His research on Low molecular weight heparin also deals with topics like

• Anticoagulant that intertwine with fields like Prospective cohort study, Enoxaparin sodium, Warfarin and Heparin,
• Inferior vena cava which is related to area like Heparin-induced thrombocytopenia. His biological study spans a wide range of topics, including Pulmonary embolism, Antithrombotic and Intensive care medicine.

His most cited work include:

• Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (827 citations)
• Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) (581 citations)
• Neuroendocrine tumor epidemiology: contrasting Norway and North America. (384 citations)

What are the main themes of his work throughout his whole career to date?

Anthony K.C. Chan mainly focuses on Internal medicine, Thrombosis, Pediatrics, Heparin and Surgery. His Internal medicine research incorporates themes from Gastroenterology, Endocrinology, Immunology and Cardiology. Anthony K.C. Chan works mostly in the field of Thrombosis, limiting it down to concerns involving Intensive care medicine and, occasionally, MEDLINE and Clinical trial.

His study in Pediatrics is interdisciplinary in nature, drawing from both Odds ratio, Epidemiology, Cohort study, Prospective cohort study and Risk factor. His Heparin study incorporates themes from Anticoagulant and Pharmacology. His Anticoagulant research is multidisciplinary, relying on both Anesthesia, Warfarin and Antithrombotic.

He most often published in these fields:

• Internal medicine (32.89%)
• Thrombosis (25.22%)
• Pediatrics (23.68%)

What were the highlights of his more recent work (between 2016-2021)?

• Internal medicine (32.89%)
• Thrombosis (25.22%)
• Pediatrics (23.68%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Thrombosis, Pediatrics, Incidence and Heparin. His Thrombosis study combines topics from a wide range of disciplines, such as Hemostasis, Rivaroxaban and Clinical trial. Anthony K.C. Chan interconnects Randomized controlled trial, Intensive care medicine, Brain ischemia, Disease and Prospective cohort study in the investigation of issues within Pediatrics.

His research in Incidence intersects with topics in Epidemiology and Cohort study. His primary area of study in Heparin is in the field of Low molecular weight heparin. His Low molecular weight heparin research integrates issues from Anticoagulant and Fondaparinux.

Between 2016 and 2021, his most popular works were:

• American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. (87 citations)
• Epidemiology and Outcomes of Arterial Ischemic Stroke in Children: The Canadian Pediatric Ischemic Stroke Registry. (85 citations)
• Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial (41 citations)

In his most recent research, the most cited papers focused on:

• Internal medicine
• Surgery
• Cancer

His primary scientific interests are in Thrombosis, Pediatrics, Internal medicine, MEDLINE and Rivaroxaban. His research integrates issues of Adverse effect, Incidence and Cohort study in his study of Thrombosis. His studies deal with areas such as Randomized controlled trial, Brain ischemia, Disease, Evidence-based medicine and Low molecular weight heparin as well as Pediatrics.

Anthony K.C. Chan frequently studies issues relating to Surgery and Internal medicine. He has researched Surgery in several fields, including Gastroenterology and National Health and Nutrition Examination Survey. His work in MEDLINE tackles topics such as Intensive care medicine which are related to areas like Venous thromboembolism.